Unknown

Dataset Information

0

Chicago Healthy Aging Study: objectives and design.


ABSTRACT: Investigators in the Chicago Healthy Aging Study (CHAS) reexamined 1,395 surviving participants aged 65-84 years (28% women) from the Chicago Heart Association Detection Project in Industry (CHA) 1967-1973 cohort whose cardiovascular disease (CVD) risk profiles were originally ascertained at ages 25-44 years. CHAS investigators reexamined 421 participants who were low-risk (LR) at baseline and 974 participants who were non-LR at baseline. LR was defined as having favorable levels of 4 major CVD risk factors: serum total cholesterol level <200 mg/dL and no use of cholesterol-lowering medication; blood pressure 120/?80 mm Hg and no use of antihypertensive medication; no current smoking; and no history of diabetes or heart attack. While the potential of LR status in overcoming the CVD epidemic is being recognized, the long-term association of LR with objectively measured health in older age has not been examined. It is hypothesized that persons who were LR in 1967-1973 and have survived to older age will have less clinical and subclinical CVD, lower levels of inflammatory markers, and better physical performance/functioning and sleep quality. Here we describe the rationale, objectives, design, and implementation of this longitudinal epidemiologic study, compare baseline and follow-up characteristics of participants and nonparticipants, and highlight the feasibility of reexamining study participants after an extended period postbaseline with minimal interim contact.

SUBMITTER: Pirzada A 

PROVIDER: S-EPMC3816341 | biostudies-literature | 2013 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications


Investigators in the Chicago Healthy Aging Study (CHAS) reexamined 1,395 surviving participants aged 65-84 years (28% women) from the Chicago Heart Association Detection Project in Industry (CHA) 1967-1973 cohort whose cardiovascular disease (CVD) risk profiles were originally ascertained at ages 25-44 years. CHAS investigators reexamined 421 participants who were low-risk (LR) at baseline and 974 participants who were non-LR at baseline. LR was defined as having favorable levels of 4 major CVD  ...[more]

Similar Datasets

| S-EPMC6031009 | biostudies-literature
| S-EPMC2071967 | biostudies-other
| S-EPMC4579264 | biostudies-literature
| S-EPMC3168750 | biostudies-literature
| S-EPMC4744991 | biostudies-literature
| S-EPMC7034269 | biostudies-literature
| S-EPMC4516898 | biostudies-other
| S-EPMC7225045 | biostudies-literature
| S-EPMC5662692 | biostudies-literature
| S-EPMC8235045 | biostudies-literature